- Prebiotics for Infant Formula, particularly those containing galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), are gaining traction for promoting healthy gut microbiota, boosting immunity, and supporting overall infant health
- Market demand is largely driven by the shift toward functional and fortified baby food, increased penetration of international infant formula brands, and greater healthcare professional endorsements for prebiotic inclusion
- The growing preference for close-to-breastmilk substitutes and increasing focus on pediatric nutrition innovation are expected to further accelerate the adoption of prebiotic-enriched infant formulas in Europe
- Germany dominated the Europe prebiotics for infant formula market in 2024, accounting for the largest revenue share of 47.36%, driven by a strong healthcare infrastructure, premium consumer preferences, and a robust presence of scientific research in infant nutrition
- U.K. is witnessing fastest growth rate of 8.89%, backed by rising awareness of gut microbiome development in infants. Parents are increasingly opting for premium formulas featuring HMOs, PDX, and inulin, while local manufacturers and global players expand product lines to address both nutritional quality and allergen-free options
- The Human Milk Oligosaccharides (HMOs) segment dominated the market with the largest revenue share of 36.4% in 2024, owing to their close resemblance to naturally occurring prebiotics found in breast milk
